Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women()

BACKGROUND: A 9-valent human papillomavirus (HPV6/11/16/18/31/33/45/52/58; 9vHPV) vaccine was developed to expand coverage of the previously developed quadrivalent (HPV6/11/16/18; qHPV) vaccine. METHODS: Efficacy, immunogenicity, and safety outcomes were assessed in Latin American participants enrol...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Papillomavirus Res
Principais autores: Ruiz-Sternberg, Ángela María, Moreira, Edson D., Restrepo, Jaime A., Lazcano-Ponce, Eduardo, Cabello, Robinson, Silva, Arnaldo, Andrade, Rosires, Revollo, Francisco, Uscanga, Santos, Victoria, Alejandro, Guevara, Ana María, Luna, Joaquín, Plata, Manuel, Dominguez, Claudia Nossa, Fedrizzi, Edison, Suarez, Eugenio, Reina, Julio C., Ellison, Misoo C., Moeller, Erin, Ritter, Michael, Shields, Christine, Cashat, Miguel, Perez, Gonzalo, Luxembourg, Alain
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5887018/
https://ncbi.nlm.nih.gov/pubmed/29269325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pvr.2017.12.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados